Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

Saartje Uyttebroek; Lieven Dupont; Jeroen Wagemans; Rob Lavigne; Maya Merabishvili; Tom Coenye; Laura Van Gerven

doi:10.1002/alr.23441

Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

Saartje Uyttebroek
, Lieven Dupont
, Jeroen Wagemans
, Rob Lavigne
, Maya Merabishvili
, Tom Coenye
, Laura Van Gerven

Laboratory for Molecular and Cellular Technology

University Hospital Gasthuisberg
KU Leuven
University of Ghent

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

Résumé

Key points: Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO₃ salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.

langue originale	Anglais
Pages (de - à)	73-76
Nombre de pages	4
journal	International Forum of Allergy and Rhinology
Volume	15
Numéro de publication	1
Les DOIs	https://doi.org/10.1002/alr.23441
état	Publié - janv. 2025

Accès au document

10.1002/alr.23441

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{162e577fd85c4259aba11621b5e95fbb,

title = "Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis",

abstract = "Key points: Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO3 salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.",

keywords = "CRS, bacteriophages, biofilm, chronic rhinosinusitis, phage, treatment",

author = "Saartje Uyttebroek and Lieven Dupont and Jeroen Wagemans and Rob Lavigne and Maya Merabishvili and Tom Coenye and \{Van Gerven\}, Laura",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). International Forum of Allergy \& Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.",

year = "2025",

month = jan,

doi = "10.1002/alr.23441",

language = "English",

volume = "15",

pages = "73--76",

journal = "International Forum of Allergy and Rhinology",

issn = "2042-6976",

number = "1",

}

TY - JOUR

T1 - Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

AU - Uyttebroek, Saartje

AU - Dupont, Lieven

AU - Wagemans, Jeroen

AU - Lavigne, Rob

AU - Merabishvili, Maya

AU - Coenye, Tom

AU - Van Gerven, Laura

N1 - Publisher Copyright: © 2024 The Author(s). International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.

PY - 2025/1

Y1 - 2025/1

N2 - Key points: Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO3 salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.

AB - Key points: Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO3 salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.

KW - CRS

KW - bacteriophages

KW - biofilm

KW - chronic rhinosinusitis

KW - phage

KW - treatment

UR - https://www.scopus.com/pages/publications/85202879611

U2 - 10.1002/alr.23441

DO - 10.1002/alr.23441

M3 - Article

AN - SCOPUS:85202879611

SN - 2042-6976

VL - 15

SP - 73

EP - 76

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

IS - 1

ER -

Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

Résumé

Accès au document

Autres fichiers et liens

Empreinte digitale

Contient cette citation